Synopsys, Inc. (NASDAQ:SNPS) Holdings Raised by Dai ichi Life Insurance Company Ltd

Dai ichi Life Insurance Company Ltd increased its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 72.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 27,619 shares of the semiconductor company's stock after acquiring an additional 11,595 shares during the quarter. Dai ichi Life Insurance Company Ltd's holdings in Synopsys were worth $14,221,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Venturi Wealth Management LLC purchased a new stake in Synopsys during the third quarter valued at about $27,000. Annis Gardner Whiting Capital Advisors LLC purchased a new position in Synopsys in the 3rd quarter valued at approximately $29,000. Catalyst Capital Advisors LLC raised its holdings in Synopsys by 34.5% during the 3rd quarter. Catalyst Capital Advisors LLC now owns 113 shares of the semiconductor company's stock valued at $52,000 after acquiring an additional 29 shares during the period. Keener Financial Planning LLC purchased a new stake in shares of Synopsys during the fourth quarter worth $56,000. Finally, Altshuler Shaham Ltd boosted its stake in Synopsys by 157.1% in the 4th quarter. Altshuler Shaham Ltd now owns 126 shares of the semiconductor company's stock worth $65,000 after purchasing an additional 77 shares during the period. 85.47% of the stock is owned by hedge funds and other institutional investors.

Synopsys Trading Down 0.5 %

NASDAQ:SNPS traded down $2.85 during trading hours on Tuesday, reaching $571.53. 579,235 shares of the company traded hands, compared to its average volume of 1,138,728. Synopsys, Inc. has a 1 year low of $390.20 and a 1 year high of $629.38. The stock has a market capitalization of $87.16 billion, a P/E ratio of 62.94, a P/E/G ratio of 3.31 and a beta of 1.07. The business's 50-day moving average price is $557.14 and its two-hundred day moving average price is $545.80.

Synopsys (NASDAQ:SNPS - Get Free Report) last released its quarterly earnings data on Wednesday, February 21st. The semiconductor company reported $3.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.43 by $0.13. Synopsys had a return on equity of 22.88% and a net margin of 22.96%. The business had revenue of $1.65 billion for the quarter, compared to analysts' expectations of $1.65 billion. During the same period in the prior year, the firm posted $1.75 EPS. The firm's quarterly revenue was up 21.1% on a year-over-year basis. As a group, equities analysts anticipate that Synopsys, Inc. will post 9.78 EPS for the current year.

Insider Activity at Synopsys

In related news, CEO Sassine Ghazi sold 10,294 shares of Synopsys stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $577.51, for a total value of $5,944,887.94. Following the completion of the sale, the chief executive officer now owns 61,863 shares of the company's stock, valued at $35,726,501.13. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Synopsys news, insider John F. Runkel, Jr. sold 1,219 shares of the company's stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $583.95, for a total value of $711,835.05. Following the completion of the sale, the insider now owns 26,780 shares in the company, valued at $15,638,181. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Sassine Ghazi sold 10,294 shares of Synopsys stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $577.51, for a total value of $5,944,887.94. Following the transaction, the chief executive officer now directly owns 61,863 shares in the company, valued at $35,726,501.13. The disclosure for this sale can be found here. Insiders have sold a total of 26,832 shares of company stock worth $15,464,992 over the last quarter. Company insiders own 0.66% of the company's stock.

Analyst Ratings Changes

A number of research firms have recently commented on SNPS. Needham & Company LLC restated a "buy" rating and set a $660.00 price target on shares of Synopsys in a research report on Friday, March 22nd. Piper Sandler initiated coverage on Synopsys in a research note on Thursday, April 4th. They issued an "overweight" rating and a $665.00 target price on the stock. Robert W. Baird lifted their price target on Synopsys from $624.00 to $640.00 and gave the company an "outperform" rating in a research report on Thursday, February 22nd. StockNews.com upgraded shares of Synopsys from a "hold" rating to a "buy" rating in a research report on Monday, March 18th. Finally, Rosenblatt Securities reaffirmed a "buy" rating and issued a $615.00 target price on shares of Synopsys in a research note on Thursday, March 21st. Eleven research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus price target of $601.00.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.